Piasky (Crovalimab

Piasky (crovalimab-akkz) is a complement C5 inhibitor used for the treatment of adult and pediatric patients aged 13 years and older with paroxysmal nocturnal hemoglobinuria (PNH) and body weight of at least 40 kg.

Recommended Dosage: The recommended dosage for Piasky (crovalimab-akkz), used for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), is as follows:

• Day 1: A loading dose of 1000 or 1500 mg via intravenous infusion.
• Days 2, 8, 15, and 22: A subcutaneous injection of 340 mg each day.
• Maintenance Doses: Starting from Day 29, a subcutaneous injection of 680 or 1020 mg every four weeks, depending on the patient’s body weight.

If a dose is missed, take it as quickly as possible before the next scheduled dose. Resume the regular dosing schedule after that. Do not take two doses or more in one day to make up for a missed dose. 

• Treatment with Piasky 340 mg/2 mL can cause severe allergic reactions, including anaphylaxis. Monitor patients closely during and after administration. Discontinue use immediately if a severe hypersensitivity reaction occurs.
• Crovalimab-akkz can increase the risk of serious infections. Patients should be monitored for signs of infection during treatment and for a period following the conclusion of therapy. Consider prophylactic measures in high-risk patients.
• Development of anti-drug antibodies (ADAs) to crovalimab-akkz may occur, potentially affecting drug efficacy. Monitor for reduced clinical response.
• Infusion reactions, including fever, chills, and hypotension, may occur. Pre-medicate patients with antihistamines and corticosteroids if necessary, and have resuscitative measures available.
• Piasky may cause liver enzyme elevations. Regular monitoring of liver function tests is recommended. Discontinue if significant liver enzyme elevations or hepatotoxicity occur.
• The safety of Crovalimab 340 mg/2 mL injection during pregnancy and breastfeeding has not been established. Use only if the potential benefit justifies the potential risk to the fetus or infant.
• Evaluate potential drug interactions with other medications the patient is taking. Adjust dosages as necessary to avoid adverse interactions. 

What documents are required to import PIASKY to India?

PIASKY (crovalimab-akkz) injections can be imported by patients or government hospitals on the name of the patients only. 

The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order be confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
  
• Import permit if applicable

PIASKY (crovalimab injections) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability of Piasky in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
  
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
  
• Medicine Price.
  
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
  
• Ensuring 100% transparency.

IPN (Indian Pharma Network) can facilitate the supply of PIASKY (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Piasky 340 mg/2 mL price in India. 

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source the PIASKY (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Piasky®?

Crovalimab-akkz is a Generic Name for the trade name drug Piasky®.

What is the manufacturer’s name for Piasky®?

Piasky® is manufactured by Genentech, Inc.

Is Piasky® approved by the FDA?

Yes, Piasky® is approved by the FDA. Date of first approval: June 20, 2024.

What is the dosage and form of Piasky® supplied?

Piasky® is supplied as Injections: 340 mg/2 mL (170 mg/mL) in a single-dose vial for intravenous or subcutaneous administration. 

What are the most common side effects of Piasky®? 

The most common side effects of Piasky® are respiratory tract infection, infusion-related reactions, viral infection, and Type III hypersensitivity reactions.

How much does Piasky® cost in India?

Prices may fluctuate over time due to market dynamics and regulatory changes. To obtain accurate and up-to-date information on the cost of Piasky injections in India, it is recommended to Call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

Can Piasky® be made available in SAARC countries? 

Apart from Gulf countries, Piasky® can be available in SAARC countries (Nepal, Pakistan, Afghanistan, Bangladesh, Bhutan, India, Maldives, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the supply of Piasky® in these countries, ensuring access to this therapeutic through legal and reliable channels.

What are the storage conditions of Piasky®?

Store refrigerated at 2-8°C (36-46°F) in the outer carton to protect from light. Neither freeze nor shake it.

Is it safe to buy Piasky® online in India?

Yes, one can buy Piasky online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in the country. We can help facilitate the supply of Piasky® through legal channels.